Eli Lilly and Company (LLY): Price and Financial Metrics
Today's Latest Price: $169.13 USD
Jul 8 4:10pm Add LLY to Watchlist Sign Up LLY Stock Summary LLY has a higher market value than 99.08% of US stocks; more precisely, its current market capitalization is $159,622,015,267. The capital turnover (annual revenue relative to shareholder's equity) for LLY is 7.5 -- better than 94.87% of US stocks. LLY's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 96.41% of US stocks. If you're looking for stocks that are quantitatively similar to ELI LILLY & Co, a group of peers worth examining would be AMGN, NVO, ORCL, AZN, and ABT. Visit LLY's SEC page to see the company's official filings. To visit the company's web site, go to www.lilly.com. LLY Price/Volume Stats
161.76B Eli Lilly and Company (LLY) Company Bio
Eli Lilly discovers, develops, manufactures, and sells pharmaceutical products worldwide. It operates in two segments, Human Pharmaceutical Products and Animal Health products. The company was founded in 1876 and is based in Indianapolis, Indiana.
LLY Latest News Stream
All News Types Acquisition Barron's Commentary Corp. News Cramer Debt Offering Dividend Downgrade Earnings Guidance Down Guidance Up Job Cuts M&A Marijuana Mgmt Change New Coverage (Bullish) New Coverage (Neutral) Options Product News PT Lowered PT Raised PT Set (Bearish) PT Set (Bullish) PT Set (Neutral) Rating Reiterated (Bearish) Rating Reiterated (Bullish) Rating Reiterated (Neutral) Resumes Coverage (Bullish) Rumor Spin-off Trump Upgrade
Event/Time News Detail Loading, please wait... Latest LLY News From Around the Web
Below are the latest news stories about ELI LILLY & Co that investors may wish to consider to help them evaluate LLY as an investment opportunity.
Eli Lilly ([[LLY]] +1.3%) will collaborate with privately held Sermonix in an open-label Phase 2 clinical trial, ELAINE 2, evaluating the combination of Verzenio (abemaciclib) and the latter's lead drug lasofoxifene in pre- and postmenopausal women with locally advanced/metastatic ER+/HER2- breast cancer and an ESR1 mutation. Enrollment should launch this...
Eli Lilly (LLY) closed the most recent trading day at $169.13, moving +1.43% from the previous trading session.
The company has a strong pipeline of antibody-drug conjugates Continue reading...
Nine months after reviving trials of a key Alzheimer's treatment, Biogen has submitted an application for a 'priority review' to the Food & Drug Administration.
Pharmaceutical stocks dipped by a single-digit percentage in the first six months of 2020, trailing their biotech brethren. Still, there are standout companies in the group.
Read More 'LLY' Stories Here
LLY Price Returns
25.39% Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
Page generated in 0.9558 seconds.